Geriatric Oncology: Chemotherapy Toxicity in the Geriatric Population
EVENT DETAILS AND REGISTRATION
Date:September 01, 2016
Time: 05:30 PM - 08:00 PM (PT)
Location:Visitor Center, City of Hope, Duarte, CA
Arti Hurria, MD • Director, Cancer and Aging Research Program • Co-leader, Cancer Control and Population Sciences Program • Associate Professor, Department of Medical Oncology & Therapeutics Research and Department of Population Sciences Dane
- Integrate a comprehensive geriatric assessment (CGA) into the evaluation of the elderly patient; to include such factors as comorbidity, functional status, physical performance, cognitive status, nutritional status, medication review, and social support.
- Assess an individual patient's risk of severe toxicity from chemotherapy by utilizing the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
- Demonstrate the utility of a greater awareness of geriatric assessment, which will aid in appropriate drug therapy selection and dosing based not just on pharmacology, but on individual patient physiology, thereby allowing a greater number of older cancer patients to benefit from treatment with reduced and manageable morbidity.
- Implement an individualized cooperative multidisciplinary treatment plan for the geriatric oncology patient.
Who should attend:Medical Oncologists, Radiation Oncologists, Gerontologists, Internists, and other allied health care professionals who treat geriatric patients with cancer.
CME credits:1.5 - AMA PRA Category 1TM
R.S.V.P.: Click here to register